Levetiracetam Treatment of Neonatal Seizures: A Multi-Centre Randomized Blinded Controlled Study of the Efficacy of Oral Levetiracetam as First Line Treatment for Neonatal Seizures in China

Trial Profile

Levetiracetam Treatment of Neonatal Seizures: A Multi-Centre Randomized Blinded Controlled Study of the Efficacy of Oral Levetiracetam as First Line Treatment for Neonatal Seizures in China

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 30 Mar 2016

At a glance

  • Drugs Levetiracetam (Primary) ; Phenobarbital
  • Indications Neonatal seizures
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Mar 2016 Planned End Date changed from 1 Dec 2018 to 1 Dec 2020, according to ClinicalTrials.gov record.
    • 23 Mar 2016 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019, according to ClinicalTrials.gov record.
    • 23 Mar 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top